17.37
0.45 (2.66%)
| 前收盘价格 | 16.92 |
| 收盘价格 | 16.86 |
| 成交量 | 118,458 |
| 平均成交量 (3个月) | 162,222 |
| 市值 | 1,068,545,152 |
| 价格/销量 (P/S) | 60.23 |
| 股市价格/股市净资产 (P/B) | 10.13 |
| 52周波幅 | |
| 利润日期 | 27 Mar 2025 |
| 稀释每股收益 (EPS TTM) | -0.920 |
| 总债务/股东权益 (D/E MRQ) | 7.75% |
| 流动比率 (MRQ) | 11.88 |
| 营业现金流 (OCF TTM) | -36.34 M |
| 杠杆自由现金流 (LFCF TTM) | -17.92 M |
| 资产报酬率 (ROA TTM) | -36.70% |
| 股东权益报酬率 (ROE TTM) | -67.31% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Instruments & Supplies (US) | 看跌 | 混合的 |
| Medical Instruments & Supplies (全球的) | 看跌 | 混合的 | |
| 股票 | Pulse Biosciences, Inc | 混合的 | 混合的 |
AIStockmoo 评分
| 分析师共识 | -2.0 |
| 内部交易活动 | NA |
| 价格波动 | 2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 4.0 |
| 平均 | 1.00 |
|
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems. |
|
| 部门 | Healthcare |
| 行业 | Medical Instruments & Supplies |
| 投资方式 | Small Growth |
| 内部持股比例 | 73.90% |
| 机构持股比例 | 9.00% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Panoramic Capital, Llc | 31 Dec 2024 | 48,571 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合